Skip to main content
Caplight Logo









TheraPPI Bioscience

TheraPPI Bioscience

Private
LyonHealthcare & Life Scienceshttps://tppibio.com/

Last Round

Debt

Dec 18, 2025

Total Funding Raised

$490,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

TheraPPI Bioscience is a biotechnology company that develops small molecule drugs targeting protein-protein interactions to treat cancer, rare diseases, and inflammatory conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

small-molecule drugsprotein-protein interactionsPPIRAS-MAPK pathwayoncology drug developmentdrug resistancepreclinical biotechrare disease therapeuticsdrug discoverymedicinal chemistrybiotech licensingtranslational biologypharma partneringdrug pipelinewet-lab research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TheraPPI Bioscience Comparables

Compare TheraPPI Bioscience with similar companies based on industry and business-model similarity.

TheraPPI Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Johnson & Johnson
79%
Balto Pharmaceuticals
77%
Step Pharma
76%

TheraPPI Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtDec 18, 2025
Pre SeedFeb 9, 2025
GrantFeb 5, 2024
SeedNov 16, 2023

Key People

Founding team and executive leadership

Luc Otten

Chief Executive Officer And Founder

Founding Team

TheraPPI Bioscience Investors

Notable investors and investment history

TheraPPI Bioscience investors
InvestorRounds
FongitSeed, Pre Seed
PulsalysPre Seed
BpifranceDebt, Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 3, 2026

    Grew 60% QoQ, from 5 to 8 employees.

  • Dec 18, 2025

    $300K round with Bpifrance

TheraPPI Bioscience Filings

Explore SEC and related filing metadata, where available.

TheraPPI Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TheraPPI Bioscience's valuation, stock price, and market status.

Is TheraPPI Bioscience a public or private company?

TheraPPI Bioscience is a private company.

What is the current stock price of TheraPPI Bioscience?

TheraPPI Bioscience is a private company with no public stock price. Caplight tracks TheraPPI Bioscience's secondary market activity and provides MarketPrice estimates to Caplight users.

How much is TheraPPI Bioscience worth (valuation)?

Valuation information for TheraPPI Bioscience is not publicly available.

Can I buy TheraPPI Bioscience stock?

TheraPPI Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TheraPPI Bioscience's last funding round?

TheraPPI Bioscience's most recent funding round was Debt on December 18, 2025.

Who are the main investors in TheraPPI Bioscience?

Key investors in TheraPPI Bioscience include Fongit, Pulsalys, Bpifrance.

Will TheraPPI Bioscience IPO soon?

No public IPO plans have been announced for TheraPPI Bioscience.

How can I track TheraPPI Bioscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TheraPPI Bioscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLyon
Employee Range3
Year Founded2023
Last FundingDec 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?